Preparation, characterization, and in vitro evaluation of the anticancer activity of Ce 3+ doped CuFe 2 O 4 spinel nanoparticles in MCF- 7 cell lines

Author:

Sheena T. V1,Jyothish B.1,Jacob John1

Affiliation:

1. Christian College

Abstract

Abstract In the current study, Ce-doped Copper ferrite, CuCexFe2-xO4(x=0.00, 0.03, and 0.05) particles in the nano range were prepared successfully by using the chemical co-precipitation technique. The structure, composition, optical properties, and morphological information of the obtained ferrite nanoparticles (NPs) were analyzed by making use of powder X-Ray diffraction (PXRD) pattern, Field Emission Scanning Electron Microscopic (FE-SEM) studies, Fourier Transform Infrared Spectroscopic (FT-IR) analysis, and Energy-dispersive X-Ray Spectroscopy (EDS), and the UV-Vis-NIR Spectroscopy. The MTT [3- 9(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide] test was utilized to examine the in vitro anti-cancer activities against the breast cancer MCF-7 cell line, which shows the dose-dependent cell survival within the range of concentration 6.25µg/mL-100µg/mL. In vitro cytotoxicity studies have shown that CuCexFe2-xO4 (x = 0.05) nanoparticles (NPs) were proved to be safe at lower concentrations, indicating their biocompatibility. However, higher concentrations (>25 g/mL) of the NPs lowered the cell viability and disrupted the cell lines of L929 fibroblasts. The ability of the nanoparticles to induce apoptosis in human breast cancer cells were studied by double staining method and flow cytometry and it was noted that apoptosis is one of the mechanism by which it induces cytotoxic effect on MCF-7 cell lines.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3